MG
APYX icon

Michael Gelband’s Apyx Medical APYX Stock Holding History

Michael Gelband’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.2K Buy
+14,069
New +$55.8K ﹤0.01% 1478
2026
Q1 		– Sell
-87,115
Closed -$305K – 1535
2025
Q4 		$305K Buy
+87,115
New +$304K ﹤0.01% 1308
2019
Q2 		– Sell
-103,453
Closed -$653K – 1085
2019
Q1 		$653K Buy
103,453
+76,976
+291% +$596K 0.05% 267
2018
Q4 		$172K Buy
+26,477
New +$160K 0.01% 281

Other funds holding APYX

RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Michael Gelband's APYX Position: Q2 2026 in Review

Michael Gelband opened a new position in Apyx Medical (APYX) in Q2 2026: 14,069 shares worth $63.2K. The stake represents ﹤0.01% of the portfolio and ranks #1478 among its holdings. This is a return to the name: Michael Gelband previously reported a position in APYX as recently as Q4 2025.

Michael Gelband first reported a position in APYX in Q4 2018 and has held it in 4 quarters since. The position peaked at $653K in Q1 2019. 68 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

  • Michael Gelband held 14,069 shares of Apyx Medical worth $63.2K as of Q2 2026.
  • Apyx Medical was a new Michael Gelband position in Q2 2026.
  • Apyx Medical made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1478 holding.
  • Michael Gelband first reported a position in Apyx Medical in Q4 2018 and has held it in 4 quarters since.
  • Michael Gelband's Apyx Medical position peaked at $653K in Q1 2019.
  • 68 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.